deltaDOT is a spin out company from Imperial College London UK - a team of scientists and
engineers dedicated to the advancement of analytical techniques using patented methods and
instrumentation in High Performance Capillary Electrophoresis (HPCE). We design and
produce HPCE instruments which we are marketing worldwide. We also use the same
instruments to offer Analytical Services and Contract Research. Our offices and laboratories
are based in the London Bioscience Innovation Centre (LBIC).
Who we are
High Performance Capillary Electrophoresis (HPCE) analytical instruments are designed,
manufactured and marketed by deltaDOT. These instruments use deltaDOT’s proprietary
imaging and analysis technology called Label Free Intrinsic Imaging (LFII®). High
Performance Capillary Electrophoresis and Label Free Intrinsic Imaging applied to a CE
analytical system offers dramatically improved discovery power in comparison to other
conventional CE systems.
deltaDOT team of scientists has developed considerable expertise in CE based analysis and in
solving clients’ analytical problems. Using our own HPCE LFII® analytical instruments we also
offer Analytical Services and Contract Research to industry and academia from our
laboratories in the London Bioscience Innovation Centre.
& Contract Research
High Performance Capillary Electrophoresis (HPCE) is applied in Life Sciences research, drug
testing, diagnostics and bio-pharmaceutical manufacturing. This technology is used in
detection, separation and analysis of proteins, nucleic acids, carbohydrates, viruses and
bacteria, chemicals and a wide range of other analytes. More detail can be found on our
Antibody Analysis, Amino Acid Analysis, Transferrin, Small Molecules, Peptides, Complex
Protein Lysates, Recombinant Human Erythropoietin, Antibiotics in food products, Glycoforms,
DNA, RNA, Chemicals, Baculovirus Titre.
Glomerular filtration rate (GFR) determined by Iohexol clearance was developed in
collaboration with Royal Veterinary College for renal failure diagnosis in companion animals
12-14 March 2015, 2nd International Conference on Label-Free Technologies
Boston Marriott Cambridge, MA, USA. Dr. Stuart Hassard will be speaking on Label
free intrinsic imaging high performance capillary electrophoresis - a powerful tool in
4th, 5th March 2015 Keeping pace - Analytics for tomorrow’s biopharmaceuticals
conference, Leeds, UK. Dr. Stuart Hassard will be speaking on Label free intrinsic
imaging high performance capillary electrophoresis trends throughout
biopharmaceutical process analytical technology.
21st October 2014 deltaDOT CSO Dr. Stuart Hassard to co-Chair BBSRC Strategic
Tools and Resources Development Fund committee in November (...more).
18 October 2014 deltaDOT’s Label-free HPCE-512 - a key instrument in accurate
analysis of drug-antibody complexes (DAR); see a recent Paper “Next generation
maleimides enable the controlled assembly of antibody–drug conjugates via native
disulfide bond bridging” (...more).
12 August 2014 deltaDOT and the Royal Veterinary College partnership have
launched a new therapeutic drug monitoring service. The service offered is a
measure of glomerular filtration rate (GFR) in companion animals, widely
considered to be the gold standard test for kidney function (more...)
10 July 2014 deltaDOT will be participating in London Vet Show on 20th and 21st
November 2014. The exhibition will be held at London's Olympia and deltaDOT will
be showcasing their HPCE technology featuring applications for Veterinarians.
deltaDOT in conjunction with Royal Veterinary College developed a novel method
for HPCE application in tests for glomerular filtration rate (GFR) in companion
animals. This novel method, using Iohexol (Omnipaque), is now available to
Veterinarians. deltaDOT will be on stand C60.
30 April 2014 deltaDOT and the Royal Veterinary College have introduced a
kidney function test for companion animals. Using deltaDOT High Performance
Capillary Electrophororesis system (HPCE-512) the company performs Iohexol
(Omnipaque) glomerular filtration rate (GFR) analysis for Veterinarians in the in the
UK. deltaDOT are actively looking for partners to expand this test into Europe and
18 December 2013 deltaDOT chosen as supplier to National Center for
Therapeutics Manufacturing, College Station, Texas. London, UK, - deltaDOT Ltd
announced the sale of their HPCE-512 instruments to the Texas A&M Center for
Innovation in Advanced Development and Manufacturing (CIADM). The
implementation of the HPCE-512 technology at the CIADM will facilitate the
establishment of enhanced analytical capabilities in the Center’s facilities ...more
18 June 2012 Texas A&M System Awarded National Center for Innovation.
deltaDOT Ltd. is a partner in BARDA funded international consortium. $285.6 million
public-private partnership to enhance the nation’s biosecurity preparedness and
create jobs in Texas (...more)